219 related articles for article (PubMed ID: 23496027)
1. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
Ganesan S; Ito MK
Metab Syndr Relat Disord; 2013 Aug; 11(4):251-5. PubMed ID: 23496027
[TBL] [Abstract][Full Text] [Related]
2. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
Berthold HK; Naini A; Di Mauro S; Hallikainen M; Gylling H; Krone W; Gouni-Berthold I
Drug Saf; 2006; 29(8):703-12. PubMed ID: 16872244
[TBL] [Abstract][Full Text] [Related]
3. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin enhances induction of inducible nitric oxide synthase in 3T3-L1 adipocytes.
Araki S; Dobashi K; Asayama K; Shirahata A
Free Radic Res; 2007 Sep; 41(9):1028-34. PubMed ID: 17729120
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
7. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells.
Genvigir FD; Rodrigues AC; Cerda A; Hirata MH; Curi R; Hirata RD
Drug Metabol Drug Interact; 2011; 26(1):33-6. PubMed ID: 21417795
[TBL] [Abstract][Full Text] [Related]
8. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
[TBL] [Abstract][Full Text] [Related]
9. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Robinson JG; Davidson MH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
Maeda T; Horiuchi N
J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
[TBL] [Abstract][Full Text] [Related]
12. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia.
Krysiak R; Okopien B
J Cardiovasc Pharmacol; 2011 Apr; 57(4):505-12. PubMed ID: 21297492
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 does not improve peripheral insulin sensitivity in statin-treated men and women: the LIFESTAT study.
Kuhlman AB; Morville T; Dohlmann TL; Hansen M; Kelly B; Helge JW; Dela F
Appl Physiol Nutr Metab; 2019 May; 44(5):485-492. PubMed ID: 30273493
[TBL] [Abstract][Full Text] [Related]
14. Statin treatment and new-onset diabetes: a review of proposed mechanisms.
Brault M; Ray J; Gomez YH; Mantzoros CS; Daskalopoulou SS
Metabolism; 2014 Jun; 63(6):735-45. PubMed ID: 24641882
[TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
16. Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.
Moutzouri E; Liberopoulos EN; Florentin M; Liamis G; Elisaf MS
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):13-8. PubMed ID: 22539817
[TBL] [Abstract][Full Text] [Related]
17. Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia.
Koh KK; Oh PC; Sakuma I; Kim EY; Lee Y; Hayashi T; Han SH; Park YM; Shin EK
Int J Cardiol; 2015 Nov; 199():126-31. PubMed ID: 26188833
[TBL] [Abstract][Full Text] [Related]
18. Hydroxymethylglutaryl--CoA reductase inhibitor inhibits induction of nitric oxide synthase in 3T3--L1 preadipocytes.
Dobashi K; Araki S; Kubo K; Kawagoe R; Yamamoto Y; Shirahata A
Life Sci; 2008 Jan; 82(1-2):85-90. PubMed ID: 18036617
[TBL] [Abstract][Full Text] [Related]
19. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
Vaverková H
Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
[TBL] [Abstract][Full Text] [Related]
20. Effects of orexin A on GLUT4 expression and lipid content via MAPK signaling in 3T3-L1 adipocytes.
Shen Y; Zhao Y; Zheng D; Chang X; Ju S; Guo L
J Steroid Biochem Mol Biol; 2013 Nov; 138():376-83. PubMed ID: 23907013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
